RARE DISEASES & ORPHAN DRUGS

RARE DISEASES & ORPHAN DRUGS

Products
RARE DISEASES & ORPHAN DRUGS
RARE DISEASES & ORPHAN DRUGS

Information

Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products. USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets. Many products are made in USA products in FDA approved facilities.
Distribution Areas
Middle East Region (e.g. UAE)Central America (e.g. Mexico)South America (e.g. Brazil, Colombia)South East Asia (e.g. Thailand, Philippines, Singapore)
All categories
Biopharmaceutical ProductsBiosimilarsImmunologyBiopharmaceutical ServicesProductsServices
Main Categories
Biopharmaceutical ProductsBiopharmaceutical Services
Lodaat PharmaLODAAT Pharma is a USA firm with a portfolio of high value molecules including Biosimilars, Biologics, Rare Disease, Orphan Drugs. Our consumer health group is renowned for innovation in OTC in all major therapeutic categories including pain management, inflammation and gut microbiome. We are a leading investor in innovator drugs, ADCs, NCEs and new drug development for oncology, immunology, diabetes, cardiovascular, and other therapeutics. We look for leading global partners for out-licensing and want to expand their portfolios. www.Lodaatpharma.com

Log in

See all the content and easy-to-use features by logging in or registering!